Liver grafts discarded for transplantation because of macrosteatosis can constitute a valuable source of human hepatocytes for in vitro metabolic and pharmacotoxicological studies or for therapeutic applications. A condition for using hepatocyte suspensions for these purposes is the preservation of their metabolic competence and, particularly, drug-metabolizing enzymes. A reduction in microsomal cytochrome P450 (P450) activities was observed in fatty livers (>40% steatosis) with respect to normal tissue. Similarly, decreased levels of 7-ethoxycoumarin O-deethylation and testosterone metabolism were observed in human hepatocyte cultures prepared from steatotic liver tissue. To clarify the potential impact of lipid accumulation on human hepatic P450 enzymes, we have used an in vitro model of "cellular steatosis" by incubation of cultured hepatocytes with increasing concentrations (0.25-3 mM) of long-chain free fatty acids (FFA). A dose-dependent accumulation of lipids in the cytosol is induced by FFA mixture. Hepatocytes exposed to 1 mM FFA for 14 h showed lower activity values of CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2D6, CYP2E1, and CYP3A4 enzymes than nontreated hepatocytes (about 45-65% reduction). This treatment also produced significant decreases in CYP1A2, CYP2A6, CYP2C9, CYP2D6, CYP2E1, and CYP3A4 mRNA to about 55 to 75% of mRNA levels in control cells. Our results suggest that although human hepatocytes isolated from steatotic liver show reduced P450 activities, they are metabolically competent and can be used for drug metabolism studies.
Primary human hepatocytes are recognized as a suitable cellular model for the study of metabolism and pharmacotoxicological effects of drugs (Gómez-Lechón et al., 2004 ). However, a major limitation for their expanded use is the lack of a regular supply of adequate amounts of the tissue required to sustain a research program and, related to this, the quality of the tissue. Healthy human liver is only occasionally available for experimental purposes, and this scarcity is increased by the competing demands for human cells for clinical applications, such as hepatocyte transplantation programs or artificial liver devices. Normal liver resected during therapeutic hepatectomies, remnants of livers after reduction or split-liver procedures, and human cadaveric livers thought unsuitable for transplantation are potentially good sources of high-quality isolated hepatocytes (Baccarani et al., 2003; Mitry et al., 2003; Serralta et al., 2003; Barbich et al., 2004; Haghighi et al., 2004) . High-grade macrosteatosis and cirrhosis are the two principal reasons for organ refusal for transplantation. Steatotic livers give better results, in terms of cell yield, than cirrhotic organs from hepatocyte isolation procedures (Baccarani et al., 2003) . A key question is the functionality of cells isolated from fatty livers.
Steatosis has been considered as a condition predictive of failure of liver transplantation from cadaveric donors and, consequently, for discarding liver tissue. The implantation of livers from cadaveric donors with severe fatty infiltration is frequently associated with early hepatic dysfunction and an increased incidence of primary nonfunction after liver transplantation (Todo et al., 1989) . More recent data show that even mild steatosis negatively affects graft and patient survival (Marsman et al., 1996) . A clinical consensus exists that grafts with severe steatosis (Ͼ60%) should be discarded, whereas grafts with mild steatosis (Ͻ30%) may be used (Imber et al., 2002; Koneru and Dikdan, 2002) . However, the impact of hepatic steatosis on the outcome of hepatocyte transplantation and/or culture has not yet been determined. The quality of isolated cells to be used for transplantation has been usually assessed based on cellular viability, plating efficiency, or plasma protein mRNA expression after a short period of culture (Baccarani et al., 2003; Mitry et al., 2003; Lloyd et al., 2004) . Some discrepancies have been found in predictions of hepatocyte functionality after transplantation based on viability of isolated cells and survival in primary culture (Olinga et al., 2000; Nishitai et al., 2005) . The functional competence of hepatocytes should also be used as an indication of the quality of cell preparations (Serralta et al., 2003) . Among other hepatic functions, hepatocytes to be used for transplantation purposes or for in vitro metabolic and pharmacotoxicologic studies must maintain their drug-metabolizing capability. Preservation of phase I and phase II enzyme activities, and particularly those catalyzed by cytochromes P450 (P450), the major system responsible for oxidative metabolism of drugs and other xenobiotics, is a key condition for therapeutic and/or experimental applications of hepatocytes.
The aim of the present study was to investigate the potential effects of liver steatosis on drug-metabolizing capacity of hepatocytes. To this end, we have developed an experimental model of cellular steatosis based on the incubation of primary cultured human hepatocytes with long-chain free fatty acids (FFA), as previously reported in HepG2 cells (Feldstein et al., 2003) . The effects of fat-overloading on individual P450 were analyzed at both the P450 monooxygenase activity and mRNA levels. The results indicate that in vitro fatoverloading of hepatocytes results in a down-regulation of several P450 enzymes involved in drug metabolism, which could explain the lower metabolic capability found in human hepatocytes isolated from steatotic livers.
Materials and Methods
Chemicals. Collagenase and ␤-glucuronidase/arylsulfatase were obtained from Roche (Barcelona, Spain). Culture media (Ham's F-12, Lebovitz L-15), newborn calf serum, and DNase I Amplification Grade were from Gibco BRL (Paisley, UK). Nile red, oleate, palmitate, cytochrome c, 7-ethoxycoumarin, 7-hydroxycoumarin, coumarin, 7-benzoxyresorufin, chlorzoxazone, diclofenac, resorufin, testosterone, 16␣-and 11␤-hydroxytestosterone (OHT), androstenedione, and 4-methylumbellipherone were purchased from Sigma (Madrid, Spain). 7-Methoxyresorufin was from Molecular Probes Europe BV (Leiden, The Netherlands). 4Ј-Hydroxydiclofenac, 6-hydroxychlorzoxazone, hydroxybufuralol, midazolam, 1Ј-hydroxymidazolam, phenacetin, acetaminophen, and 2␤-, 6␤-, 15␤-, and 16␤-OHT were supplied by Ultrafine (Manchester, UK). All the other chemicals were of analytical grade.
Preparation of Microsomes from Human Liver Tissue. Samples of human liver tissue from cadaveric organ donors were obtained in conformance to the rules of the Hospital's Ethics Committee. The tissue was obtained in the bank surgery, and it was transported in a cold University of Wisconsin preservation solution. All the liver samples were from donors who were not suspected of harboring any infectious disease and tested negative for human immunodeficiency virus and hepatitis. The extent of steatosis was graded by pathological examination, and only nonsteatotic livers (n ϭ 10, 6 male and 4 female, patients aged between 15 and 71 years, mean 49 Ϯ 18) or those classified as steatotic (Ͼ40%, pathologist confirmation) (n ϭ 9, 6 male and 3 female, patients aged between 19 and 69 years, mean 44 Ϯ 21) were included in the study. After reception, liver samples were immediately dissected into small pieces, frozen in liquid nitrogen, and stored at Ϫ80°C until used. To prepare liver microsomes, tissue was homogenized in 50 mM Tris HCl, pH 7.4, containing 150 mM KCl and 1 mM EDTA. Homogenates were centrifuged at 10,000g for 20 min at 4°C, and the supernatant obtained (S9 fraction) was subsequently centrifuged at 100,000g for 1 h at 4°C. The microsomal pellet was resuspended in 100 mM phosphate buffer, pH 7.4, containing 1 mM EDTA, quickly frozen in liquid nitrogen, and stored in aliquots at Ϫ80°C. Protein content was determined by the method of Lowry et al. (1951) .
Isolation and Culture of Human Hepatocytes. Seventeen nonsteatotic (11 male and 6 female, age 48 Ϯ 19 years) and 16 steatotic (9 male and 7 female, age 52 Ϯ 14) liver grafts were used for cell harvesting. Tissue samples were obtained and transported as described above for livers used for microsome preparation. Nonsteatotic elective liver biopsies (1-4 g) obtained in the course of therapeutic laparotomy for nonmalignant liver disease or extrahepatic disease after receiving informed consent from patients, in conformity with the rules of the Hospital's Ethics Committee, were also used. None of the patients were habitual consumers of alcohol or other drugs. All the liver samples, cadaveric and elective, were from donors who were not suspected of harboring any infectious disease and tested negative for human immunodeficiency virus and hepatitis. No underlying malignant liver pathology was present in any of the cases. Hepatocytes were isolated using a two-step perfusion technique and cultured as described in detail elsewhere (Gómez-Lechón et al., 1990) . Cellular viability was assessed by the trypan blue dye exclusion test. Hepatocytes were seeded on fibronectin-coated plastic dishes. The medium was changed 1 h later to remove unattached hepatocytes. By 24 h, the cells were shifted to serum-free hormone-supplemented medium (10 nM dexamethasone and insulin).
Fat-Overloading Induction in Cultured Hepatocytes. To induce fatoverloading of cells, primary cultures of human hepatocytes prepared from elective nonsteatotic liver biopsies were exposed to a mixture of FFA (2:1 ratio of oleate and palmitate) (Feldstein et al., 2003) . Stock solutions of 50 mM oleate and 50 mM palmitate prepared in culture medium containing 1% bovine serum albumin were conveniently diluted in culture medium to obtain the desired final concentrations (0.25-3 mM). Long-chain FFA mixture was added to cultures 6 to 8 h after medium renewal. Fat content was determined fluorimetrically by Nile red staining (McMillian et al., 2001) . Briefly, hepatocyte monolayers were washed twice with phosphate-buffered saline (PBS) and incubated for 15 min with Nile red solution at a final concentration of 1 mg/ml in PBS at 37°C. Monolayers were washed thereafter with PBS and read in a microfluorometer (excitation 488 nm and emission 550 nm). Cytotoxicity of FFA was assessed by measuring neutral red uptake (Babich and Borenfreund, 1992) .
Measurement of Phase I and Phase II Activities in Human Liver Microsomes. P450 activities were assayed by incubating microsomes (100 g of protein) for 15 min at 37°C in 300 l of 100 mM phosphate buffer, pH 7.4, containing NADPH-regenerating system (5 mM Cl 2 Mg, 1 mM NADP ϩ , 10 mM glucose 6-phosphate, and 0.3 U/ml glucose-6-phosphate dehydrogenase) and the appropriate substrate. Substrate concentrations for P450 assays were as follows: 500 M 7-ethoxycoumarin, 10 M 7-methoxyresorufin (CYP1A2), 50 M coumarin (CYP2A6), 200 M diclofenac (CYP2C9), 250 M chlorzoxazone (CYP2E1), and 200 M testosterone (CYP3A4). 7-Methoxyresorufin O-demethylation (MROD) assay was stopped by adding 300 l of methanol, and the resorufin formed was determined fluorimetrically as described (Donato et al., 1993a) . Coumarin 7-hydroxylation (CH) and 7-ethoxycoumarin O-deethylation (ECOD) assays were stopped with 30 l of 25% trichloroacetic acid, and 7-hydroxycoumarin formation was quantified fluorimetrically (355 nm excitation and 460 nm emission) as previously described (Edwards et al., 1984) . The diclofenac 4Ј-hydroxylation (D4OH) and chlorzoxazone 6-hydroxylation (C6OH) assays were stopped by adding 300 l of acetonitrile, and the metabolites formed were analyzed by high-performance liquid chromatography (HPLC) (Bort et al., 1999) . Testosterone oxidation assays were stopped with 500 l of ethyl acetate, and hydroxylated metabolites were extracted and analyzed by HPLC as described elsewhere (Donato et al., 1993b) . NADPH-P450 reductase (CPR) activity was assayed using cytochrome c as substrate as described (Guzelian et al., 1977) . UDP-glucuronyltransferase (GT) activity was assayed using 4-methylumbellipherone as substrate (Donato et al., 1999) .
Evaluation of Metabolic Competence of Human Hepatocytes. Activity assays were performed by direct incubation of cell monolayers with the substrates. Hepatocytes were incubated at 37°C with 800 M 7-ethoxycoumarin, 200 M testosterone, 10 M methoxyresorufin, 15 M benzoxyresorufin, 10 M phenacetin, or 100 M coumarin for 1 h (metabolite formation was linear for at least 2 h) or with 300 M diclofenac, 400 M chlorzoxazone, 5 M midazolam, or 10 M bufuralol for 3 h (linearity of the assays was Ͼ4 h). Reactions were stopped by aspirating the incubation medium from plates, and medium samples were then incubated with ␤-glucuronidase and arylsulfatase for 2 h at 37°C (Donato et al., 1993a) . Metabolites formed during ECOD, MROD, CH, D4OH, C6OH, or testosterone oxidations were quantified fluorimetrically or by HPLC analysis as described above for microsomal assays. Resorufin formed during the 7-benzozyresorufin O-debenzylation (BROD) assay was determined fluorimetrically as described (Donato et al., 1993a) . Analysis of metabolites formed during phenacetin O-deethylation (PHE), midazolam 1Ј-hydroxylation (MID), and bufuralol 1Ј-hydroxylation (BUF) assays was conducted by HPLC/tandem mass spectrometry (MS/MS). The LC/MS/MS system comprised a Micromass Quattro Micro triple quadrupole mass spectrometer equipped with an electrospray ionization source interfaced with an Alliance Waters 2795 liquid chromatograph (Waters, Milford, MA). An aliquot (20 l) was injected onto a Teknokroma C18 column (100 ϫ 2.1 mm, 3-m particle size) operated at 40°C. The flow rate was 0.4 ml/min. Mobile phase was 0.1% formic acid in acetonitrile, A, and 0.1% formic acid in water, B. The proportion of acetonitrile was increased linearly from 0 to 90% in 6 min, and then the injection column was allowed to re-equilibrate at initial conditions for 10 min. The column eluent was directed to an atmospheric pressure ionization interface without splitting, operating at 320°C using nitrogen as auxiliary gas (400 or 600 l/h). For quantification, the mass spectrometer was operated in the selected multiple reaction monitoring mode to monitor for detecting metabolites of phenacetin, midazolam, and bufuralol selecting the 152 Ͼ 110, 342 Ͼ 324, and 278 Ͼ 186 m/z ion transitions, respectively. Dextromethorphan at final concentration of 0.2 pM was used as internal standard, following the ion transition 258 Ͼ 157. To evaluate accuracy, quality controls of each compound were prepared and used to ensure linearity and intra-assay precision and accuracy.
Measurement of mRNA by Reverse Transcription-Polymerase Chain Reaction. Total RNA was extracted from cultured human hepatocytes using TRIzol RNA extraction kit (Life Technologies) following the supplier's recommendations. The amount of purified RNA was estimated by RiboGreen fluorescence (Molecular Probes), and its purity was assessed by the absorbance ratio 260:280 nm. RNA integrity was examined by electrophoresis in a 1% agarose gel on ethidium bromide staining. The reverse transcription reaction mixture consisted of 1 g of total RNA, which was reverse-transcribed in 20 l of reverse transcriptase buffer, 10 mM DTT, 500 M deoxynucleotides, 3 M oligo(dT)14 primer, 60 U RNase, and 250 U reverse transcriptase. The reaction was allowed to proceed for 60 min at 42°C, followed by 5-min heating at 95°C and then rapid cooling on ice. The cDNA was stored at Ϫ20°C until use. The polymerase chain reaction was conducted in semiautomatic equipment (Roche, Light-Cycler). The conditions used for the quantitative polymerase chain reaction, the specific primers, and the quantification strategy were as previously described (Pérez et al., 2003) .
Statistical Analysis. Data are expressed as mean Ϯ S.D. Comparisons of variables between groups were performed using Student's t test, and p Ͻ 0.05 was assumed statistically significant.
Results

Xenobiotic-Metabolizing Activities in Steatotic or Nonsteatotic
Liver Grafts. The evaluation of the metabolic capacity of the tissue requires functional studies at activity level. Selected phase I and phase II drug-metabolizing enzyme activities were measured in microsomes obtained from fatty livers (Ͼ40% macrosteatosis) and compared with those found in nonsteatotic livers. Activity levels of CPR and different P450 enzymes were determined as representative of phase I reactions.
Similar CPR activities were found in microsomes from steatotic and nonsteatotic livers (Table 1) . ECOD activity is catalyzed by several human P450 (Waxman et al., 1991; Yamazaki et al., 1996) and is commonly measured as a representative estimation of total P450 activity (Donato et al., 1999) . Lower, but not significantly lower, ECOD activity was observed in fatty livers (Table 1) . Evaluation of the activity of individual P450 enzymes requires the use of appropriate substrates for each individual P450 enzyme. 7-Methoxyresorufin, coumarin, testosterone, diclofenac, and chlorzoxazone were chosen as isozyme-selective substrates for the evaluation of P450 enzymes in liver microsomes (Table 1) . From these five selective reactions, only MROD (CYP1A2) and 6␤-OHT (CYP3A4) activities were significantly decreased in microsomes from livers with steatosis. Similar activity levels of GT activity, a phase II enzyme, were found in both groups of livers (Table 1) .
Testosterone is metabolized in a regioselective manner by different P450 enzymes, and it can be used as a substrate to investigate the activity of several P450 enzymes simultaneously. Comparative analysis of testosterone metabolic profile in both groups of livers revealed a lower oxidative metabolism in microsomes from liver grafts with steatosis (Table 2 ). Significant differences were observed for 6␤-and 2␤-OHT activities (CYP3A4). Microsomes from the steatotic group also showed lower (about 40 -50% of liver group without steatosis) rates of formation of 16␤-OHT and androstenedione, representative of CYP2C9 and CYP2C19 activities, respectively, although these differences were not significant.
Metabolic Competence of Primary Cultures of Human Hepatocytes Prepared from Steatotic or Nonsteatotic Livers.
Hepatocytes were isolated from 17 different human liver samples with steatosis (Ͼ40%) or nonsteatosis (n ϭ 16). The use of steatotic livers led to a significant reduction in the yield of the isolation procedure, estimated as the number of viable cells obtained per gram of liver tissue, with respect to nonsteatotic livers (6.1 Ϯ 5.0 versus 15.8 Ϯ 9.5 million hepatocytes/g of tissue, p Ͻ 0.05). No significant differences in the viability of hepatocytes freshly isolated from steatotic or normal livers were found (82 Ϯ 23% versus 94 Ϯ 5%, p ϭ 0.1). By 24 h of culture, functional competence of primary cultures was evaluated by measuring P450-dependent oxidations. To this end, ECOD activity was quantified as representative of total P450 activity, and 6␤-OHT was evaluated as a selective probe for CYP3A4, the major P450 enzyme in human liver. For both P450 activities, high variability was observed among individual donors. As an average, cell preparations obtained from livers with steatosis showed significantly lower ECOD a Activities were measured in liver microsomes using selective substrates and expressed as picomoles of corresponding metabolite formed per minute and per milligram of protein, except in the case of CPR, D4OH, C6OH, and GT, which were expressed in nanomoles per minute and per milligram of protein. Results are mean Ϯ S.D. of different microsomal preparations from nonsteatotic (n ϭ 10) or steatotic (n ϭ 9) livers.
b Percentage with respect to the corresponding activity value in nonsteatosis group. c For each microsomal preparation, phase I activities were normalized respect to CPR activity values. Results are mean Ϯ S.D. of different microsomal preparations from nonsteatotic (n ϭ 10) or steatotic (n ϭ 9) livers.
* p Ͻ 0.05 with respect to nonsteatosis group.
(12.3 Ϯ 8.6 versus 19.7 Ϯ 8.7 pmol/mg ϫ min) and 6␤-OHT (39.0 Ϯ 34.5 versus 94.7 Ϯ 63.5 pmol/mg ϫ min) activity values than those of hepatocytes from nonsteatotic samples (Fig. 1) . The oxidative metabolism of testosterone was analyzed as an additional parameter to estimate drug-metabolizing capacity of cultured cells. Human hepatocytes in primary culture actively convert the substrate to several hydroxylated metabolites. Total testosterone oxidation was significantly lower in hepatocytes prepared from liver grafts with steatosis than in cultures from normal liver (133 Ϯ 75 versus 266 Ϯ 151 pmol/mg ϫ min, p Ͻ 0.05). Similarly, the rate of formation of each testosterone metabolite was lower in hepatocytes from livers with steatosis. However, independently of these quantitative differences, no appreciable changes in the relative rates of each testosterone hydroxylation reaction were found, and consequently, the profiles of testosterone metabolites obtained from both groups of hepatocytes were highly similar (Fig. 2) . 6␤-OHT (CYP3A4) and androstenedione (CYP2C19) were the major metabolites formed in all the hepatocyte preparations, followed by 2␤-OHT (CYP3A4), 15␤-OHT (CYP3A4), 16␣-OHT, and 16␤-OHT (CYP2C9).
P450 Expression in an in Vitro-Induced Model of Hepatic Steatosis. Differences in drug-metabolizing activities observed in cultures obtained from both groups of livers could be partially caused by other factors than fat content of the liver. In an attempt to discriminate changes in hepatocyte P450 function caused exclusively by steatosis, we studied effects on metabolic capability of hepatocytes using an in vitro model of induced steatosis. To this end, human hepatocytes obtained from normal livers were incubated with increasing concentrations of FFA mixture (2:1 ratio of oleate to palmitate) for 14 or 36 h. Hepatocytes treated with FFA developed dose-dependent accumulation of lipid droplets in the cytosol that could be quantified using Nile red as a vital lipophilic dye to label fat accumulation (Fig.  3A) . Maximal lipid accumulation was reached after hepatocyte incubation for 14 h with 1 mM FFA, showing a relative lipid loading comparable with that of hepatocytes obtained from the liver of patients with steatosis (data not shown). No cytotoxic effects were observed after hepatocyte incubation with FFA mixture up to 2 mM during 14 h (Fig. 3B) . After longer exposure (36 h) to FFA, significant reductions in hepatocyte viability were observed at concentrations Ͼ1 mM. Noncytotoxic treatments were selected for further treatment of hepatocytes to explore the potential effects of fat accumulation on functional competence of cultured cells.
Comparison of testosterone metabolite profiles of cultured hepatocytes treated with FFA mixture with those of cells maintained in control medium showed a dose-dependent reduction in testosterone oxidation rates of fat-overloaded cells, with no changes in the relative formation of each metabolite (Table 3 ). Significant decreases in testosterone metabolism were observed after 14 h of exposure of hepatocytes to 1 or 2 mM FFA (about 60 -40% and 50 -20% of control, respectively). Greater effects on P450 activities were observed after 36 h of treatment with 1 mM FFA mixture (36-h treatment with 2 mM FFA was cytotoxic) (Fig. 3B) . These results, in a Major P450 involved in the formation of the hydroxylated metabolites are indicated (Donato et al., 1999) . b Activities are expressed as picomoles of the corresponding product formed per minute and per milligram of microsomal protein. Results are mean Ϯ S.D. of nine different microsomal preparations from nonsteatotic or steatotic livers.
c Percentage with respect to the corresponding activity value in nonsteatosis group. * p Ͻ 0.05 with respect to nonsteatosis group. agreement with the lower testosterone oxidative capacity observed in microsomes and cultured hepatocytes prepared from liver grafts with steatosis (Table 2 and Fig. 1 ), suggested a general reduction in P450-dependent function in fat-overloaded hepatocytes. To confirm these findings, the effects of fat-overloading on major human P450 enzymes were analyzed using selective reactions, namely, MROD and PHE (CYP1A2), CH (CYP2A6), BROD (CYP2B6), D4OH (CYP2C9), MID and 6␤-OHT (CYP3A4), BUF (CYP2D6), and C6OH (CYP2E1). Exposure of cultured hepatocytes to 2 mM FFA for 12 h resulted in significant decreases (to 20 -50% of controls) of activity levels of all the individual P450 enzymes examined, as well as in ECOD activity (indicative of several P450) (Fig. 4) . Significant reductions in CYP1A2 (MROD), CYP2A6, CYP2B6, CYP2C9, and CYP3A4 activities were also produced by 1 mM FFA. Levels of mRNA corresponding to CYP1A2, CYP2A6, CYP2C9, CYP2D6, CYP2E1, and CYP3A4 were also quantified in fatoverloaded hepatocytes. As seen in Fig. 5 , human hepatocytes exposed to 1 mM FFA mixture for 14 h showed lower mRNA content corresponding to the six P450 enzymes examined than did control hepatocytes.
Discussion
The aim of the present study was to determine the suitability of fatty liver tissue as a source of metabolically competent hepatocytes to be used for therapeutic or research purposes. To this end, P450 activities were comparatively measured in primary cultures of hepatocytes isolated from human liver tissue with or without macrosteatosis. Reductions in ECOD (catalyzed by several P450 enzymes) and 6␤-OHT (CYP3A4) reactions were observed in hepatocyte cultures prepared from steatotic livers (Fig. 1) . These results are in agreement with the decrease in microsomal P450 activities found in fatty livers relative to normal tissue (Table 1) . We observed significant reductions in CYP3A4 (6␤-OHT) and CYP1A2 (MROD) activities in liver tissue with steatosis, whereas minor changes or no effects were observed in other activities. Unless individual P450 enzymes were equally affected by steatosis, an altered pattern of P450 activities would be found in hepatocytes isolated from fatty livers. Consequently, notable differences in the metabolic profile of a particular drug could be found as a function of the grade of steatosis present in the tissue used for cell harvesting. Potential effects of fat accumulation on individual drugmetabolizing enzymes are difficult to analyze in human liver because high interindividual variability in P450 is commonly found (Gómez-Lechón et al., 2004) . A number of factors such as age, sex, pathological status (infections, inflammation, cirrhosis, carcinoma, and fibrosis), or drug intake (chemotherapy, alcohol consumption, and smoking habits) are known to contribute to differences between donors (Kraul et al., 1991; Pelkonen and Breimer, 1994) . Increased levels of CYP2E1, together with a reduction in CYP3A, have been found in patients with nonalcoholic steatohepatitis (Weltman et al., 1998) . However, up to now, the potential role of liver steatosis on the regulation of major human P450 has not been exhaustively examined, and the possible mechanisms responsible for these changes remain unknown. Previous studies undertaken in nutritional models of hepatic steatosis in experimental animals suggested an association between lipid deposition and impaired P450 function (Weltman et al., 1996;  Leclercq et al., 1998; Su et al., 1999) . Decreased P450 activities and protein levels were observed with the appearance of steatosis, and moreover, significant correlations between P450 activities and liver fat content have been found (Leclercq et al., 1998) .
In the present study, we have used an in vitro model of fatoverloaded hepatocytes to investigate the impact of steatosis in P450 enzymes excluding other factors that could influence hepatocyte behavior. Hepatocytes from normal (nonsteatotic) liver samples were treated with or without FFA mixture. FFA-treated hepatocytes developed "cellular steatosis" (Fig. 3) , and drug-metabolizing capability was compared with that of control hepatocytes obtained from the same liver sample. A significant reduction in the activity and mRNA levels of some individual P450 enzymes was found in fat-overloaded hepatocytes (Figs. 4 and 5) , which confirmed the lower metabolic capability observed in hepatocytes prepared from steatotic liver tissue (Fig. 1) . Our results provide evidence of a reduction in several P450 involved in drug metabolism. The impairment of P450 activities in in vitro fat-overloaded hepatocytes can be explained, at least in part, by the reduction in specific mRNA levels of P450 enzymes. These findings support the hypothesis that down-regulation of P450 could occur at a pretranslational level by interfering with transcriptional activation of the genes or by increasing mRNA degradation. However, other mechanisms could be involved in the observed reduction in P450 function as a result of fat accumulation. Modification of the lipid composition of microsomal membranes could affect optimal association between P450 and CPR and/or cytochrome b 5 , altering the functional capacity of the P450 system (Leclercq et al., 1998; Su et al., 1999) .
Previous studies in animal models of induced steatosis suggested reductions in CYP2C, CYP3A, and, to a minor extent, CYP2A enzymes (Weltman et al., 1996; Leclercq et al., 1998; Su et al., 1999) . However, conflicting data on the regulation of CYP2E1 in liver steatosis have been reported. Increases in CYP2E1 have been observed in rodent models of liver steatosis with inflammation (Weltman et al., 1996; Leclercq et al., 2000) , as well as in patients with nonalcoholic steatohepatitis (Weltman et al., 1998) , whereas a reduction in CYP2E1 expression has been reported in animal models of hepatic steatosis in the absence of inflammation (Leclercq et al., 1998) . It was suggested that CYP2E1 increases observed in steatohepatitis are not directly linked to fat accumulation but could be more closely related to the inflammatory process (Leclercq et al., 1998) . Several cytokines released during the inflammatory process have been shown to down-regulate the expression of different hepatic P450 enzymes, whereas others seemed to be involved in the up-regulation of CYP2E1 (Abdel-Razzak et al., 1993; Donato et al., 1993b; Guillen et al., 1998) . Our results showed that changes in CYP2E1 mRNA content and catalytic activities observed in fat-overloaded human hepatocytes are similar to those found in the other P450 enzymes studied, suggesting a similar mechanism of down-regulation for the different P450 (Figs. 4 and 5) . To our knowledge, this is the first study in which seven different human P450 enzymes have been comparatively examined in a model of induced steatosis.
In our in vitro model of cellular steatosis, a lower testosterone oxidation capability was found (relative to control cells) with no appreciable changes in the relative metabolite profile. Similar results were observed when comparing testosterone metabolism in hepatocytes isolated from steatotic liver grafts with those obtained from normal liver tissue. These results suggest that, despite their reduced levels of P450 activities, human hepatocytes obtained from donors with liver steatosis are metabolically competent. This finding becomes interesting because steatotic liver grafts that are considered unacceptable for orthotopic transplantation could be used for hepatocyte isolation. Severe steatosis is an absolute contraindication for liver graft transplantation because many problems have been reported, including strong correlations of high levels of macrovesicular steatosis and primary nonfunction after liver transplantation, susceptibility to ischemic injury, and impaired regeneration (Loinaz and Gonzalez, 2000; Selzner and Clavien, 2000; Imber et al., 2002; Koneru and Dikdan, 2002) . Increased hepatic fat content is frequently found in potential donors. Data from Spain show that approximately 16% of recovered livers are rejected for transplantation, and 42% of those rejections are because of hepatic steatosis (Loinaz and Gonzalez, 2000) . Although fatty livers render lower cell viability, lower yield of isolation procedure (Mitry et al., 2003; Gómez-Lechón et al., 2004) , and lower P450-dependent activities (Fig. 1 ) than nonsteatotic livers, nevertheless they can be used to obtain metabolically competent human hepatocytes. Therefore, liver grafts discarded because of macrosteatosis could constitute a valuable source of the large quantities of functional hepatocytes required for experimental purposes.
